Author: Junarta, Joey; Riley, Joshua M.; Pavri, Behzad B.
Title: Describing heart rate variability in patients with chronic atrial fibrillation during hospitalization for COVIDâ€19 Cord-id: i4njk7zl Document date: 2021_6_17
ID: i4njk7zl
Snippet: INTRODUCTION: Myriad cardiovascular manifestations have been reported with COVIDâ€19. We previously reported that failure of PR interval shortening with increasing heart rate (HR) in patients with COVIDâ€19 is associated with adverse outcomes. Here, we report on heart rate variability (HRV) and clinical outcomes in patients with chronic atrial fibrillation (cAF) hospitalized for COVIDâ€19. METHODS: A retrospective review of admitted COVIDâ€19 patients with cAF between 1 March 2020 to 30 June
Document: INTRODUCTION: Myriad cardiovascular manifestations have been reported with COVIDâ€19. We previously reported that failure of PR interval shortening with increasing heart rate (HR) in patients with COVIDâ€19 is associated with adverse outcomes. Here, we report on heart rate variability (HRV) and clinical outcomes in patients with chronic atrial fibrillation (cAF) hospitalized for COVIDâ€19. METHODS: A retrospective review of admitted COVIDâ€19 patients with cAF between 1 March 2020 to 30 June 2020 was performed. HRV in cAF was compared during preâ€COVIDâ€19 and COVIDâ€19 admissions; we selected preâ€COVIDâ€19 ECGs with HRs that were within 10 beats per minute of the COVIDâ€19 ECGs. Mean HR and each RR interval were recorded. Timeâ€domain measurements of HR variability were then calculated (SDSD, RMSSD, pNN50). Clinical outcomes during COVIDâ€19 were correlated to indices of HRV. RESULTS: A total of 184 ECGs (95 preâ€COVIDâ€19, 89 COVIDâ€19) from 38 cAF inâ€patients were included. Mean age 78.6 ± 11.4 years, male 44.7%. The mean number of ECGs analyzed per patient preâ€COVIDâ€19 was 2.50 and during COVIDâ€19 was 2.34. Comparing preâ€COVIDâ€19 versus COVIDâ€19 ECGs showed: mean HR (95.9 ± 24.3 vs. 101.6 ± 22.8 BPM; P = .10), SDSD (109.0 ± 50.6 vs. 90.3 ± 37.2 ms; P < .01), RMSSD (184.1 ± 80.4 vs. 147.3 ± 59.8 ms; P < .01), pNN50 (73.8 ± 16.3 vs. 65.6 ± 16.6%; P < .01). Patients who had a smaller pNN50 during a COVIDâ€19 admission had increased mortality (50.0% vs. 14.3%; logâ€rank test P = .02). CONCLUSION: In patients with cAF, the HRV was reduced during COVIDâ€19 compared with prior illnesses at similar average heart rates. Patients with the most depressed HRV as measured by pNN50 had an associated increase in mortality compared with patients whose HRV was preserved.
Search related documents:
Co phrase search for related documents- absolute lymphocyte count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- absolute lymphocyte count nadir and lymphocyte count: 1, 2
- absolute neutrophil count and acute kidney injury: 1
- absolute neutrophil count and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54
- acute coronary syndrome and adaptive response: 1
- acute coronary syndrome and lymphocyte count: 1, 2
- acute kidney injury and adaptive response: 1, 2, 3
- acute kidney injury and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32
- adaptive response and lymphocyte count: 1, 2, 3
Co phrase search for related documents, hyperlinks ordered by date